Skip to main content
SpringerLink
Log in

Acute Myelogenous Leukemia

  • Chapter
Cancer in Adolescents and Young Adults

Part of the book series: Pediatric Oncology ((PEDIATRICO))

  • 1314 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Creutzig U, Ritter J, Zimmermann M, et al (2001) Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Munster 93. J Clin Oncol 19:2705–2713

    PubMed  CAS  Google Scholar 

  2. Stiller CA, Benjamin S, Cartwright RA, et al (1999) Patterns of care and survival for adolescents and young adults with acute leukaemia — a population-based study. Br J Cancer 79:658–665

    Article  PubMed  CAS  Google Scholar 

  3. Bleyer WA, O’Leary M, Barr R, Ries LAG (eds) Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, including SEER Incidence and Survival, 1975–2000. National Cancer Institute, NIH Pub. No. 06-5767, Bethesda MD, June 2006; also available at www.seer.cancer.gov/publications

    Google Scholar 

  4. Ries LAG, Eisner MP, Kosary CL, et al (2003) National Cancer Institute SEER Cancer Statistics Review, 1975–2000. http://seercancergov/csr/1975_2000. National Cancer Institute, Bethesda, MD

    Google Scholar 

  5. ACCIS (2003) Automated Childhood Cancer Information System. http://www-depiarcfr/accis/datahtm

    Google Scholar 

  6. German Childhood Cancer Registry (GCCR) (2003) Annual Report 2002. http://infoimsduni-mainzde/K_Krebsregister/english/. 14-10-2003

    Google Scholar 

  7. Kaatsch P, Spix C, Michaelis J (2002) Jahresbericht 2000 Deutsches Kinderkrebsregister (1st edn) Deutsches Kinderkrebsregister, Mainz

    Google Scholar 

  8. Hjalgrim LL, Rostgaard K, Schmiegelow K, et al (2003) Age-and sex-specific incidence of childhood leukemia by immunophenotype in the Nordic countries. J Natl Cancer Inst 95:1539–1544

    PubMed  Google Scholar 

  9. Birch JM, Alston RD, Kelsey AM, et al (2002) Classification and incidence of cancers in adolescents and young adults in England 1979-1997. Br J Cancer 87:1267–1274

    Article  PubMed  CAS  Google Scholar 

  10. Reedijk AMJ, Janssen-Heijnen MLG, Louwman MWJ, et al (2005) Increasing incidence and improved survival of cancer in children and young adults in Southern Netherlands, 1973-1999. Eur J Cancer 41:760–769

    Article  PubMed  Google Scholar 

  11. Messerer D, Dugas M, Müller T, Hasford J (2003) How many patients with AML were treated in clinical trials in Germany? Rundbrief Kompetenznetz Leukämien 5:6–7

    Google Scholar 

  12. Crisphino JD (2005) GATA 1 in normal and malignant hematopoiesis. Semin Cell Dev Biol 16:137–147

    Article  CAS  Google Scholar 

  13. Hitzler JK, Zipursky A (2005) Origins of leukaemia in children with Down syndrome. Nat Rev Cancer 5:11–20.

    Article  PubMed  CAS  Google Scholar 

  14. Ge Y, Stout ML, Tatman DA, et al. (2005) GATA 1, cytidine deaminase, and the high cure rate of Down syndrome children with acute megakaryocytic leukemia. J Natl Cancer inst 97:226–231

    Article  PubMed  CAS  Google Scholar 

  15. Löning L, Zimmermann M, Reiter A, et al (2000) Secondary neoplasms subsequent to Berlin-Frankfurt-Munster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy. Blood 95:2770–2775

    PubMed  Google Scholar 

  16. Pui CH, Hancock ML, Raimondi SC, et al (1990) Myeloid neoplasia in children treated for solid tumours. Lancet 336:417–421

    Article  PubMed  CAS  Google Scholar 

  17. Bleyer WA (2002) Cancer in older adolescents and young adults: epidemiology, diagnosis, treatment, survival, and importance of clinical trials. Med Pediatr Oncol 38:1–10

    Article  PubMed  Google Scholar 

  18. Vickers M, Jackson G, Taylor P (2000) The incidence of acute promyelocytic leukemia appears constant over most of a human lifespan, implying only one rate limiting mutation. Leukemia 14:722–726

    Article  PubMed  CAS  Google Scholar 

  19. Douer D, Preston-Martin S, Chang E, et al (1996) High frequency of acute promyelocytic leukemia among Latinos with acute myeloid leukemia. Blood 87:308–313

    PubMed  CAS  Google Scholar 

  20. Hann IM, Stevens RF, Goldstone AH, et al (1997) Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council’s 10th AML trial (MRC AML10). Adult and Childhood Leukaemia Working Parties of the Medical Research Council. Blood 89:2311–2318

    PubMed  CAS  Google Scholar 

  21. Lie SO, Abrahamsson J, Clausen N, et al(2003) Treatment stratification based on initial in vivo response in acute myeloid leukaemia in children without Down’s syndrome: results of NOPHO-AML trials. Br J Haematol 122:217–225

    Article  PubMed  Google Scholar 

  22. Stevens RF, Hann IM, Wheatley K, Gray RG, on behalf of the MRC Childhood Leukaemia Working Party (1998) Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukaemia: results of the United Kingdom Medical Research Council’s 10th AML trial. Br J Haematol 101:130–140

    Article  PubMed  CAS  Google Scholar 

  23. Davies SM, Robison LL, Buckley JD, et al (2001) Glutathione S-transferase polymorphisms and outcome of chemotherapy in childhood acute myeloid leukemia. J Clin Oncol 19:1279–1287

    PubMed  Google Scholar 

  24. Büchner T, Heinecke A (1996) The role of prognostic factors in acute myeloid leukemia. Leukemia 10:S28–S29

    PubMed  Google Scholar 

  25. Wells RJ, Woods WG, Buckley JD, et al (1994) Treatment of newly diagnosed children and adolescents with acute myeloid leukemia: a Childrens Cancer Group Study. J Clin Oncol 12:2367–2377

    PubMed  CAS  Google Scholar 

  26. Wells RJ, Arthur DC, Srivastava A, et al (2002) Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia: Children’s Cancer Group Study 213. Leukemia 16:601–607

    Article  PubMed  CAS  Google Scholar 

  27. Horibe K, Tsukimoto I, Ohno R (2001) Clinicopathologic characteristics of leukemia in Japanese children and young adults. Leukemia 15:1256–1261

    Article  PubMed  CAS  Google Scholar 

  28. Büchner T, Hiddemann W, Berdel WE, et al (2003) 6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAMTAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group. J Clin Oncol 21:4496–4504

    Article  PubMed  CAS  Google Scholar 

  29. Jeha S, Smith FO, Estey E, et al (2002) Comparison between pediatric acute myeloid leukemia (AML) and adult AML in VEGF and KDR (VEGF-R2) protein levels. Leuk Res 26:399–402

    Article  PubMed  CAS  Google Scholar 

  30. Creutzig U, Zimmermann M, Reinhardt D, Büchner T (2004) AML in adolescents compared to AML in children and young adults. Proceedings of the Fourth Biennial Hannover Symposium on Childhood Leukemia, May 3–5, 2004, Hannover, Germany

    Google Scholar 

  31. Woods WG, Alonzo TA, Lange BJ, et al (2001) Acute myeloid leukemia (AML) in adolescents and young adults (AYAs): a comparison of outcomes between patients treated on childhood or adult protocols (abstract). Blood 98:462a–463a

    Google Scholar 

  32. Steinbach D, Furchtbar S, Sell W, et al (2003) Contrary to adult patients, expression of the multidrug resistance gene (MDR1) fails to define a poor prognostic group in childhood AML. Leukemia 17:470–471

    Article  PubMed  CAS  Google Scholar 

  33. Bacher U, Kern W, Schnittger S, et al (2005). Population-based age-specific incidences of cytogenetic subgroups of acute myeloid leukemia. Haematologica 90:1502–1510

    PubMed  CAS  Google Scholar 

  34. Vormoor J, Ritter J, Creutzig U, et al (1992) Acute myelogenous leukaemia in children under 2 years — experiences of the West German AML Studies BFM-78,-83 and-87. Br J Cancer 66:63–67

    Google Scholar 

  35. Ruiz-Arguelles GJ (1997) Promyelocytic leukemia in Mexican Mestizos. Blood 89:348–349

    PubMed  CAS  Google Scholar 

  36. Douer D, Estey E, Santillana S, et al (2001) Treatment of newly diagnosed and relapsed acute promyelocytic leukemia with intravenous liposomal all-trans retinoic acid. Blood 97:73–80

    Article  PubMed  CAS  Google Scholar 

  37. Guidez F, Ivins S, Zhu J, et al (1998) Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML-and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia. Blood 91:2634–2642

    PubMed  CAS  Google Scholar 

  38. Penson RT, Rauch PK, McAfee SL, et al (2002) Between parent and child: negotiating cancer treatment in adolescents. Oncologist 7:154–162

    Article  PubMed  Google Scholar 

  39. Lie SO, Jonmundsson G, Mellander L, et al (1996) A population-based study of 272 children with acute myeloid leukaemia treated on two consecutive protocols with different intensity: best outcome in girls, infants, and children with Down’s syndrome. Nordic Society of Paediatric Haematology and Oncology (NOPHO). Br J Haematol 94:82–88

    Article  PubMed  CAS  Google Scholar 

  40. Benjamin S, Kroll ME, Cartwright RA, et al (2000) Haematologists’ approaches to the management of adolescents and young adults with acute leukaemia. Br J Haematol 111:1045–1050

    Article  PubMed  CAS  Google Scholar 

  41. Bleyer A (2002) Older adolescents with cancer in North America deficits in outcome and research. Pediatr Clin North Am 49:1027–1042

    Article  PubMed  Google Scholar 

  42. Bleyer WA, Tejeda H, Murphy SB, et al (1997) National cancer clinical trials: children have equal access; adolescents do not. J Adolesc Health 21:366–373

    Article  PubMed  CAS  Google Scholar 

  43. Schiffer CA (2003) Differences in outcome in adolescents with acute lymphoblastic leukemia: a consequence of better regimens? Better doctors? Both? J Clin Oncol 21:760–761

    Article  PubMed  Google Scholar 

  44. Robison LL, Bhatia S (2003) Late effects among survivors of leukaemia and lymphoma during childhood and adolescence. Br J Haematol 122:345–359

    Article  PubMed  Google Scholar 

  45. Buzdar AU, Marcus C, Smith TL, Blumenschein GR (1985) Early and delayed clinical cardiotoxicity of doxorubicin. Cancer 55:2761–2765

    Article  PubMed  CAS  Google Scholar 

  46. Brennan BM, Shalet SM (2002) Endocrine late effects after bone marrow transplant. Br J Haematol 118:58–66

    Article  PubMed  Google Scholar 

  47. Leiper AD (2002) Non-endocrine late complications of bone marrow transplantation in childhood: part II. Br J Haematol 118:23–43

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitats-Kinderklinik, Albert-Schweitzer Str. 33, 48149, Munster, Germany

    Ursula Creutzig M.D.

  2. Children’s Hospital of Atlanta, Emory University, 2015 Uppergate Drive, GA, 30322, Atlanta, USA

    William G Woods M.D.

Authors
  1. Ursula Creutzig M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. William G Woods M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. St. Charles Medical Center, Bend, Oregon, USA

    W. Archie Bleyer

  2. McMaster University, Hamilton, Ontario, Canada

    Ronald D. Barr

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Creutzig, U., Woods, W.G. (2007). Acute Myelogenous Leukemia. In: Bleyer, W.A., Barr, R.D. (eds) Cancer in Adolescents and Young Adults. Pediatric Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-68152-6_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-68152-6_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-40842-0

  • Online ISBN: 978-3-540-68152-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation